A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s40266-016-0418-6
Published Online: 2016-11-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heise, Tim
Hövelmann, Ulrike
Zijlstra, Eric
Stender-Petersen, Kirstine
Jacobsen, Jacob Bonde
Haahr, Hanne
Funding for this research was provided by:
Novo Nordisk
License valid from 2016-11-21